As expected, a little after 1am this morning, the Senate voted 60-40 on party lines to advance a revised health care reform bill introduced Saturday morning by Senate Majority Leader Harry Reid.
All 58 Democrats and 2 independents voted to approve the first of three crucial procedural motions the Senate will consider before moving to a vote on final passage of the bill.
This afternoon, the Congressional Budget Office (CBO) released an analysis of the manager’s amendment that Senator Reid filed this morning.
Roughly 31 million Americans would receive coverage under the legislation.
CBO said that the final legislation, will cost $871 billion over the next 10 years and reduce the deficit by $132 billion over the same period.
This morning, Senator Reid introduced a manager’s amendment to the Patient Protection and Affordable Care Act. The 383 page manager’s amendment includes the deals and compromises needed to secure 60 votes on final passage, with many of the provisions targeted to satisfy the demands of individual senators.
Senator Ben Nelson (NE), the final Democratic holdout on health care, announced this morning that he will support the Senate health care reform bill.
I am using milk thistle for many of my patients, particularly the ones with some liver damage through chemotherapy or cancer.
A new study, published online in the journal Cancer, showed that milk thistle may help reduce the liver inflammation associated with chemotherapy in children with leukemia who undergo aggressive chemotherapies. Read the rest of this entry »
As a result of C3’s advocacy efforts, $15 million for a new peer reviewed cancer research program is included in the final Fiscal Year 2010 Defense Appropriations Bill.
The program will research cancers, like colorectal cancer, that are not addressed in the breast, prostate, lung and ovarian cancer research programs run by the U.S. Army Medical Research and Material Command (USAMRMC). In addition to colorectal cancer research, the funds will be used to conduct research in the following areas: melanoma and other skin cancers, pediatric brain tumors within the field of childhood cancer research, genetic cancer research and genomic medicine, kidney cancer, blood cancer, Listeria Vaccine for infectious disease and cancer, and radiation protection utilizing nanotechnology.
The $15 million in funding for this new cancer research program was included at the request of Representatives Kay Granger (R-TX) and Jim Moran (D-VA).
